Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Novel Autologous Chondrocyte Implantation Restores Young Sports-persons to Their Sport in India
  • USA - English


News provided by

MJRC CLINIC, CHENNAI

Apr 22, 2014, 04:00 ET

Share this article

Share toX

Share this article

Share toX

Chennai, Tamil Nadu (PRWEB) April 22, 2014 -- The recently introduced Autologous chondrocyte implantation is a novel procedure to treat sports persons. It repairs early cartilage damage in sports persons, and restores joints to normal. It prevents further progression to arthritis. It is thus great news for thousands of sports persons with in India.

It utilizes the patient's own cartilage cells to repair areas of cartilage damage. Largely applicable to the knee, it can also be used to repair cartilage lesions in the ankle, shoulder and possibly other large joints.

It is a two stage procedure. The first stage consists of harvesting a small piece of cartilage from the non-weight portion of the knee. This plug is sent to a laboratory in India. Here scientists extract cells from this plug and grow it several million fold in culture. The multiplied cells are sent to the surgeon after four weeks in culture. The orthopedic surgeon prepares the damaged area through a small open or key-hole procedure and implants the cells. The cells then go on to repair the damage over the next few months. After a year, original or hyaline cartilage grows back to repair the damage in most cases. In a small number, reparative cartilage grows over to cover the defect. In both cases the patients get pain relief. This procedure is a fourth generation procedure and is known as a ‘cell gell’ technique.

Orthopedic surgeon Dr.A.K.Venkatachalam, FRCS, M.Ch Orth, MS Orth, DNB Orth, (http://www.kneeindia.com) has performed this procedure in a thirty eight year old male patient.

Case report-
The patient is a business man from a neighboring country. He developed knee pain from routine activities over the course of few years. He had symptoms of pain and grinding. He consulted Dr.Venkatachalam in Chennai about three months back. High resolution MRI scans revealed two areas of cartilage damage in the patella and adjacent part of the medial femoral condyle. This was confirmed at arthroscopic evaluation. During this procedure, a small piece of cartilage was removed from the non load bearing part of the knee and dispatched to the laboratory. cartilage cells were grown to increase their number to 48 million. Four weeks later Dr.Venkatachalam implanted the cartilage by an open procedure. Usually a minimally invasive procedure is sufficient but in this case, since there were two lesions it required an open procedure to treat both of them adequately. The patient has already got pain relief. He no longer feels a grinding feeling in his knee. He has been started on a rehabilitation program. He will be wearing a range of motion knee brace for a short period and will avoid full weight bearing. He will get full mobility in his knee after three months.

Cartilage lesions are the pre cursor to osteo-arthritis. They have the potential to progress to osteo-arthritis. They are caused by sports, accidents, obesity, mal alignment and thermal injuries. Cartilage injury is suspected when the patient has long standing joint pain during activities. Initially x rays may be normal. Only high resolution MRI scans can pick it up in the early stages. Cartilage lesions are increasing in incidence all over the world. Most patients are young. They often have associated ligament injuries. Mal-alignment of the limb may be also present. The other associated injuries also need prior treatment.

To be eligible for this procedure, the patient should not be obese and have a stable knee. Additional problems should be treated prior or can be combined with this procedure.

Autologous chondrocyte implantation is a new procedure in India. It was introduced in 1994 in Sweden. It has enjoyed a good success rate abroad. Earlier techniques need a scaffold to be sutured over the defect. The current fourth generation technique uses a fibrin base cell gell technique and needs no suturing. It can be performed by key hole or minimally invasive method.

Dr.A.K.Venkatachalam is one of the few surgeons to have performed this procedure in the country. Dr.A.K.Venkatachalam specializes in joint replacements of knee, hip and shoulder. He was the first surgeon to introduce the Journey Oxinium™ knee in India. He has the distinction of tweeting the first live knee replacement in India in June 2009. He was among the first surgeons to introduce custom fit knee replacement in Chennai. He started doing neck sparing or short stem hip replacements in 2006. He also has a keen interest in arthroscopic surgery of the knee. He is one of the first to introduce bio-medical treatments like autologous chondrocyte implantation in Chennai, India.

For more information, visit http://www.kneeindia.com.

Dr.Alampallam Venkatachalam, MJRC CLINIC, CHENNAI, http://www.kneeindia.com, +91 9282165002, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.